CEO David Hallal sold $1.6M of Alexion Pharmaceuticals, Inc.

Sold$1,587,275

$140.50Price

11,297Shares

−6%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Thu, Feb 4. Filed Mon, Feb 8, 7:57 PM ET, after the close. Not investment advice.